Adagrasib → Hepatotoxicity — Null result

← All findings ⬇ Download signed audit packet

Ledger entry · null-result

Adagrasib → Hepatotoxicity — Null result

Drug: adagrasib · AE: Hepatotoxicity

Caliper validation of the submitted claim (drug=adagrasib, AE=Hepatotoxicity). BELOW_DEDUP_THRESHOLD — only 4 unique cases after dedup; insufficient signal density

Disproportionality

PRR: 3.7572675039840764 (95% CI 1.41–9.99)
Yates χ²: 5.5760470755293285
Cases (case-drug + AE): n = 4
Verdict: BELOW_DEDUP_THRESHOLD — only 4 unique cases after dedup; insufficient signal density

Top reactions in cohort

MedDRA PT	n
Hepatotoxicity	4
Alanine aminotransferase increased	1
Aspartate aminotransferase increased	1
Blood alkaline phosphatase increased	1
Gamma-glutamyltransferase increased	1
Hypoxia	1
Lung consolidation	1
Neoplasm progression	1

Source: openFDA FAERS, Caliper Engine v0. Pre-registration sha1 locked at submission time; ledger entry signed with platform Ed25519 key.

Independent Verification & Validation

Every finding includes an in-engine adversary review at no cost. For findings you plan to cite in a regulatory submission, scientific publication, or board-grade decision, we offer an additional layer of independent, audit-grade verification — reviewed by an externally-trained system that has never seen your data, your training corpus, or our hardware, and cryptographically signed.

Reference: 984d096614c22171e04756f355e7a09963e108ba